Seyeon Cindy Choi

SeYeon Cindy Choi is an accomplished professional in the field of life sciences, currently serving as a Private Equity Investor at ARCHIMED since May 2023, with a specialization in life science tools and biologic services. Concurrently, SeYeon holds the position of Board Observer at Biodextris. Previous experience includes working as a Life Sciences Strategy Consultant at ClearView Healthcare Partners from 2021 to 2023, focusing on due diligence, valuations, and opportunity assessments for private equity clients in the life sciences sector. As a co-founder of NexSense, SeYeon aimed to reduce preventable sepsis-related deaths through early detection and patient empowerment, earning recognition as a digital therapeutics category winner in the 2020 Bayer Digital Campus Challenge. Additional co-founding roles at Auditus Technologies and CraniUS involved developing innovative technologies for hearing assistance and drug delivery systems, respectively. SeYeon holds both a Master of Science in Engineering and a Bachelor of Science in Biomedical Engineering from The Johns Hopkins University, as well as a high school diploma from Shanghai American School.